Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Ching Chang

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Toxicology|January 12, 2020
Perfluorooctane sulfonate alters gut microbiota-host metabolic homeostasis in miceLimin Zhang, Bipin Rimal, Robert G Nichols, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 4, 2017
Perfluorooctane Sulfonate-Induced Hepatic Steatosis in Male Sprague Dawley Rats Is Not Attenuated by Dietary Choline SupplementationBradford D Bagley, Shu-Ching Chang, David J Ehresman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 31, 2008
Effects of perfluorobutyrate exposure during pregnancy in the mouseKaberi P Das, Brian E Grey, Robert D Zehr, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 15, 2016
Editor's Highlight: Perfluorooctane Sulfonate-Choline Ion Pair Formation: A Potential Mechanism Modulating Hepatic Steatosis and Oxidative Stress in MiceLimin Zhang, Prasad Krishnan, David J Ehresman, et al.
JCO Precision Oncology|September 11, 2020
Multiplex Gene Profiling of Cell-Free DNA in Patients With Metastatic Melanoma for Monitoring DiseaseSelena Y Lin, Sharon K Huang, Kelly T Huynh, et al.
Oncoimmunology|May 13, 2026
Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC)Rachel E Sanborn, Shawn M Jensen, Christopher Paustian, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 11, 2009
Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-alphaJennifer E Foreman, Shu-Ching Chang, David J Ehresman, et al.
Annals of Surgical Oncology|July 26, 2019
Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerJavier I J Orozco, Janie G Grumley, Chikako Matsuba, et al.
Annals of Surgical Oncology|July 26, 2019
Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic SubtypesMaggie L DiNome, Javier I J Orozco, Chikako Matsuba, et al.
The Annals of Thoracic Surgery|June 4, 2020
Not Following the Rules in Guideline Care for Lung Cancer Diagnosis and Staging Has Negative ImpactCandice L Wilshire, Joshua R Rayburn, Shu-Ching Chang, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Toxicology|January 12, 2020
Perfluorooctane sulfonate alters gut microbiota-host metabolic homeostasis in miceLimin Zhang, Bipin Rimal, Robert G Nichols, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 4, 2017
Perfluorooctane Sulfonate-Induced Hepatic Steatosis in Male Sprague Dawley Rats Is Not Attenuated by Dietary Choline SupplementationBradford D Bagley, Shu-Ching Chang, David J Ehresman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 31, 2008
Effects of perfluorobutyrate exposure during pregnancy in the mouseKaberi P Das, Brian E Grey, Robert D Zehr, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 15, 2016
Editor's Highlight: Perfluorooctane Sulfonate-Choline Ion Pair Formation: A Potential Mechanism Modulating Hepatic Steatosis and Oxidative Stress in MiceLimin Zhang, Prasad Krishnan, David J Ehresman, et al.
JCO Precision Oncology|September 11, 2020
Multiplex Gene Profiling of Cell-Free DNA in Patients With Metastatic Melanoma for Monitoring DiseaseSelena Y Lin, Sharon K Huang, Kelly T Huynh, et al.
Oncoimmunology|May 13, 2026
Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC)Rachel E Sanborn, Shawn M Jensen, Christopher Paustian, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 11, 2009
Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-alphaJennifer E Foreman, Shu-Ching Chang, David J Ehresman, et al.
Annals of Surgical Oncology|July 26, 2019
Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerJavier I J Orozco, Janie G Grumley, Chikako Matsuba, et al.
Annals of Surgical Oncology|July 26, 2019
Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic SubtypesMaggie L DiNome, Javier I J Orozco, Chikako Matsuba, et al.
The Annals of Thoracic Surgery|June 4, 2020
Not Following the Rules in Guideline Care for Lung Cancer Diagnosis and Staging Has Negative ImpactCandice L Wilshire, Joshua R Rayburn, Shu-Ching Chang, et al.
Pageof 12